MedPath

Influence of Prematurity and Its Respiratory Sequel on Exercise Testing in Childhood

Not Applicable
Completed
Conditions
The Peak Oxygen Consumption (VO2max) Was Measured and Served as the Primary Endpoint of the Study
Registration Number
NCT04833647
Lead Sponsor
Rambam Health Care Campus
Brief Summary

Prospective study comparing hemodynamic and respiratory changes and exercise capacity during Cardio-Pulmonary-Exercise-Testing (CPET) in 4 groups of infants; Three different groups of premature infants and term controls

Detailed Description

The study population included 4 groups of infants; preterm infants born \< 300 weeks' gestation with BPD (i.e. oxygen dependence for at least 28 postnatal days 5), preterm infants born \< 300 weeks' gestation without BPD, late preterm infants (born at 340-366 weeks' gestation) and term controls.

Pulmonary function testing and spirometry were measured Participants performed CPET on an electronically braked cycle ergometer. During the exercise testing, serial saturation, heart rate and blood pressure measurements were obtained.

The peak oxygen consumption (VO2max) was measured and served as the primary endpoint of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
83
Inclusion Criteria
  • 7-10 years of age
  • The ability to ride stationary bicycles as assessed by the parents.
Exclusion Criteria
  • Immobility
  • An acute febrile or upper respiratory illness in the last 2 weeks
  • The use systemic or inhaled steroids or antiepileptic drugs in the previous month
  • Inhaled bronchodilator use in the previous 24 hours
  • A chronic lung illness (with the exception of BPD and asthma)
  • Congenital cardiac defect (with the exception of atrial septal defect and patent foramen ovale).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The peak oxygen consumption (VO2max)During the 1 day test

The peak oxygen consumption (VO2max)

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.